4569 — Kyorin Pharmaceutical Share News
0.000.00%
Last trade - 00:00- ¥65bn
- ¥71bn
- ¥126bn
Table: Kyorin Holdings -2016/17 group results
Brief: Kyorin holdings likely will see 10 percent rise in group operating profit for year ending in March 2018 - Nikkei
Brief: KYORIN Holdings unit gets license from Merck for drug KRP-114V
Brief: R&I affirms KYORIN Holdings Inc's rating at "A-" and announces stable outlook -R&I
Table: Kyorin Holdings -9-MTH group results
Brief: Kyorin Holdings unit forms sales business alliance with Air Liquide Japan, Ltd.
Brief: KYORIN Holdings to transfer unit to Taisho Pharmaceutical
Table: Kyorin Holdings -6-MTH group results
Brief: KYORIN Holdings unit grants MSD K.K. manufacturing and marketing rights for medicine of allergic diseases
promotion agreement with MSD K.K
Table: Kyorin Holdings -Q1 group results
promote allergic medicine with Kyorin Holdings unit
Brief: KYORIN Holdings unit to sign exclusive distribution agreement
Table: Kyorin Holdings -2015/16 parent results
Table: Kyorin Holdings -2015/16 group results
Table: Kyorin Holdings -9-MTH group results
Table: Kyorin Holdings -2015/16 group forecast
Table: Kyorin Holdings -6-MTH group results